The largest database of trusted experimental protocols

12 protocols using transcription buffer

1

Mechanism of AID-mediated DNA Mutagenesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The 570 bp substrates for wild-type (WT) E2A, mut1, and mut2 containing the T7 promoter were generated by digestion of pDL14, pDL31, and pDL32, respectively, with BlpI and XhoI at 37°C for 2 hours in 1× CutSmart buffer followed by native PAGE (5%) purification. The recovered DNA was quantified by real-time qPCR with DL127, DL128, and DL129 (45 cycles of 94°C 30 s, 65°C 1 min).
The AID reactions containing 40 fmol/µl of GST-AID, 250 µM rNTP mix, 10 mM DTT, and 2 units/µl of T7 RNA polymerase in 1 × transcription buffer (Promega), with 5 fmol/µl of the 570 bp DNA substrate added last to initiate the transcription reaction, were incubated at 37°C for 60 min. T7 RNA polymerase was omitted for the untranscribed reactions. Where indicated, 50 ng/µl of RNase A was added at the same time as other components to the reactions. The GST-AID variant of human AID with a carboxy (C) terminal hexa-His-tag is a generous gift from Dr. Myron Goodman (Pham et al., 2019 (link)). Reactions were terminated and purified using HighPrep PCR system (MAGBIO) and then digestion with HaeII restriction enzyme at 37°C for 2 hours was done followed by another purification with HighPrep PCR system. HaeII digestion of the reaction generated a 212 bp E2A substrate containing the 23 bp E2A fragile zone which was used as template in the Maximum-Depth Sequencing (MDS) library construction described below.
+ Open protocol
+ Expand
2

CRISPR Guide RNA Design and Delivery

Check if the same lab product or an alternative is used in the 5 most similar protocols
CRISPR target sites were selected based on their proximity to the start and stop codons of the coding sequence of the targeted gene, and also by the requirement for a protospacer adjacent motif (PAM) sequence (NGG) at the 3′ end of target site. We created and annealed oligos containing a T7 promoter sequence, the target sequence, and an additional constant region to create the template for the guide RNAs (Additional file 1). These templates were transcribed in vitro using T7 RNA polymerase (Promega) in a reaction containing transcription buffer (Promega), RNase inhibitor (Promega), and rNTPs. A linearized plasmid encoding cas9 [26 (link)] was also transcribed in vitro using the Sp6 mMessage mMachine Kit (Ambion). The two guide RNAs targeting each gene were combined with cas9 mRNA and phenol red, and 1-2 nl of this mixture was injected into the cell of early 1-cell stage embryos.
+ Open protocol
+ Expand
3

Synthesis and Validation of Ltbp3 Riboprobe

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Ltbp3 probe was synthesized from PCR-generated DNA templates kindly provided by the EURExpress consortium (http://www.eurexpress.org). The template sequence is given in Supplementary Material, Fig. S3. DIG-labeled antisense riboprobe was transcribed in vitro by incubation for 2 h at 37°C using 1 µg of the PCR product, 20 U SP6 RNA polymerase, 5× transcription buffer (Promega), 10× DIG RNA labeling Mix (Roche), 0.5 M 1,4-Dithiothreitol, 20 U RNAse inhibitor (Roche) in a 20-µl volume. The reaction was stopped with 2 µl EDTA (0.2 m, pH 8), and RNA was precipitated with 1 µl yeast tRNA (10 mg/ml), 2.5 µl LiCl (4 M) and 75 µl absolute ethanol, followed by an incubation for 30 min at −80°C and centrifugation at 12 000 rpm (30 min at 4°C). The pellet was washed with 0.5 ml ethanol (70%) and re-centrifuged. The supernatant was discarded and the pellet was allowed to dry. The probe was then diluted in 20 µl sterile H2O. The quality of the probe was verified by electrophoresis in a 1% agarose gel. If no smear was observed and the size was as expected, the probe was considered to be ready for use. The quantity of RNA was evaluated by Nanodrop (ND-1000 Spectrophotometer, Labtech) and adjusted to 150 ng/µl in hybridization buffer, then stored at −20°C until use.
+ Open protocol
+ Expand
4

Mechanism of AID-mediated DNA Mutagenesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The 570 bp substrates for wild-type (WT) E2A, mut1, and mut2 containing the T7 promoter were generated by digestion of pDL14, pDL31, and pDL32, respectively, with BlpI and XhoI at 37°C for 2 hours in 1× CutSmart buffer followed by native PAGE (5%) purification. The recovered DNA was quantified by real-time qPCR with DL127, DL128, and DL129 (45 cycles of 94°C 30 s, 65°C 1 min).
The AID reactions containing 40 fmol/µl of GST-AID, 250 µM rNTP mix, 10 mM DTT, and 2 units/µl of T7 RNA polymerase in 1 × transcription buffer (Promega), with 5 fmol/µl of the 570 bp DNA substrate added last to initiate the transcription reaction, were incubated at 37°C for 60 min. T7 RNA polymerase was omitted for the untranscribed reactions. Where indicated, 50 ng/µl of RNase A was added at the same time as other components to the reactions. The GST-AID variant of human AID with a carboxy (C) terminal hexa-His-tag is a generous gift from Dr. Myron Goodman (Pham et al., 2019 (link)). Reactions were terminated and purified using HighPrep PCR system (MAGBIO) and then digestion with HaeII restriction enzyme at 37°C for 2 hours was done followed by another purification with HighPrep PCR system. HaeII digestion of the reaction generated a 212 bp E2A substrate containing the 23 bp E2A fragile zone which was used as template in the Maximum-Depth Sequencing (MDS) library construction described below.
+ Open protocol
+ Expand
5

In Vitro mRNA Synthesis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Linearized plasmid (2.5 μg) was added to a mixture containing transcription buffer (Promega), 10 mM DTT, 2.5 mM cap analog, 50 units RNasin, 200 units RNA polymerase, and 0.5 mM each UTP, ATP, CTP, GTP in a total volume of 50 uL. The reaction was incubated at 37 °C for 90 min, followed by the addition of another 200 units of polymerase and incubation for 90 additional minutes. The reaction mixture was extracted twice with phenol pH 4.5 and twice with 24:1 chloroform: isoamylalcohol. The mRNA was precipitated with ethanol, suspended in 50 ul of H2O and run though a NucAway spin column (Ambion) to remove unincorporated nucleotides. mRNA concentrations were determined using a NanoDrop spectrometer (Thermo Scientific), and samples were stored at − 80 °C until use.
+ Open protocol
+ Expand
6

Radiolabeling of RNA Transcripts

Check if the same lab product or an alternative is used in the 5 most similar protocols

32P-Labeled RNAs were transcribed in a 10 μl volume containing 20 U of T7 RNA polymerase (Promega), Transcription Buffer (Promega), 1 mM DTT (Promega), 12 U of RNasin Plus (Promega), NTP mixture (0.5 mM ATP, 0.5 mM CTP, 0.1 mM UTP and 0.1 mM GTP), 1 μg of DNA template, 1 mM m7G(5′)ppp(5′)G RNA Cap Structure Analog (New England Biolabs) and 2.96 TBq/mmol [α-32P]UTP (Perkin Elmer). Cap Structure Analog was not added for U6 snRNA or unlabeled 700 nt RNA. After a 60 min incubation at 37°C, RNA was recovered from the supernatants by phenol/chloroform extraction and purified using G-50 microcolumns (GE Healthcare). RNA was then precipitated with ethanol and dissolved in H2O.
+ Open protocol
+ Expand
7

In Vitro Transcription of β-Globin

Check if the same lab product or an alternative is used in the 5 most similar protocols
In vitro transcription was performed using 0.5 μg/μL linear β-Globin DNA in a reaction buffer containing 0.67 μM (α-32P) UTP, 0.4 mM ATP, 0.4 mM CTP, 0.1 mM UTP, 0.1 mM GTP, 2 mM m7G(5′)ppp(5′G) (cap analog), 2 mM DTT, 10 U/μL ribonuclease inhibitor, 7.5 U/μL T7 RNA polymerase (Promega) and 1× transcription buffer (Promega). Reactions were incubated at 37°C for 2 h, gel purified using denaturing PAGE, eluted from the gel (elution buffer: 0.5 mM NaOAc, pH 5.6, 0.1% SDS, 10 mM Tris, pH 7.5, 1 mM EDTA), ethanol precipitated, and resuspended in nuclease free water.
+ Open protocol
+ Expand
8

Evaluating Angiotensin 1-7 Effects on Transcription

Check if the same lab product or an alternative is used in the 5 most similar protocols
A standard in vitro RNA transcription system (Promega, Madison, WI, USA) was used to study the effects of Ang 1-7 on mRNA transcription in isolated nuclei. Freshly isolated nuclei (100 μg) were pretreated with Ang 1-7 (1 μM) alone or combined with the Mas receptor antagonist A779 (10 μM) for 30 min at 37 °C. Pre-treated nuclei were then incubated with an in vitro RNA transcription system consisting of 500 μM of ATP, GTP, and UTP; and 2 U/μl RNasin in transcription buffer (Promega) at 37 °C for 1 h. After treatments, RNA was extracted using TRIzol (Invitrogen) according to the manufacturer’s instructions. RNA (1.8 μg) was reverse transcribed to cDNA with deoxynucleotide triphosphate (dNTP), random primers, and Moloney murine leukemia virus reverse transcriptase (MMLV; 200 U; Invitrogen). In order to evaluate the expression of AT1, AT2, and MasR genes, RT-PCR was performed as described previously.
+ Open protocol
+ Expand
9

Probing snoRNA-K-Ras Protein Interactions

Check if the same lab product or an alternative is used in the 5 most similar protocols
For wild-type and mutant snoRNAs, pCR2.1TOPO vector containing snoRNAs under the control of the SP6 promoter and flanked with an SspI site at the 3′ end was used. Plasmid DNA was digested with SspI, and 4 pg of linear DNA was then in vitro transcribed in a 50-µl total volume consisting of 1× Transcription buffer (Promega), 10 mM DTT (Promega), 1 mM NTPs (Invitrogen), 40 U RNaseOUT (Invitrogen) and 60 U SP6 RNA polymerase at 37 °C for 4 h, after which DNA was digested by the addition of 2 U DNase I at 37 °C for 15 min. For gel-shift assays, 0.2 µM of the full-length or deletion-mutant forms of snoRNAs SNORD50A, SNORD50B or scrambled 74-bp (USCR) RNAs was used with the indicated amount or 0.6 µM of purified recombinant K-Ras protein (Abcam, ab96817). snoRNAs were denatured at 90 °C for 30 s in 10 µl of water, and samples were immediately transferred to ice; after adding an equal volume of 40 mM HEPES (pH 7.4) with 2 mM DTT, the sample volume was brought up to room temperature for 5 min to allow equilibration. Next, K-Ras protein was added, and samples were incubated an additional 15 min and then analyzed using a 10% TBE polyacrylamide gel; gels were scanned using a Typhoon 9410 scanner (GE Healthcare), with band intensity quantified using ImageJ software.
+ Open protocol
+ Expand
10

In Vitro Transcription and RNA Hybridization

Check if the same lab product or an alternative is used in the 5 most similar protocols
EcoRI-linearized FHV_T_Rluc and FHV_T_minus and XhoI-linearized pEAV221Δ [34 (link)] plasmids were used as templates for in vitro transcription. Transcripts of FHV_T_Rluc and FHV_T_minus corresponding to capture probes for minus and plus strands, respectively, and a transcript containing nucleotides 1-2042 of equine arteritis virus (EAV) genome were prepared using mMESSAGE mMACHINE T7 Transcription Kit (Ambion) according to the manufacturer’s instructions. In vitro transcription reactions to prepare 32P-labeled transcripts of FHV_T_Rluc and FHV_T_minus consisted of 750 ng of the respective linearized plasmid, transcription buffer (Promega), 800 U/mL T7 RNA polymerase (Promega), 1000 U/mL RiboLock (Thermo Fisher Scientific), 5 mM DTT, 1 mM ATP, UTP, GTP and CTP, and 0.133 μM α-32P-CTP (20 μCi) (Perkin Elmer, Ayer Rajah, Singapore). The reactions were incubated for 2 h at 37 °C followed by RQ1 RNase-free DNase treatment (40 U/mL; Promega) for 35 min at 37 °C and inactivation by RQ1 DNase STOP solution (Promega) for 10 min at 65 °C. Unincorporated label was removed using RNase-free Micro Bio-Spin P-30 Gel Columns (Bio-Rad). Hybridization with the 32P-labeled RNA transcripts and IVRA products was performed as described [34 (link)].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!